FDA Inspection 872670 — Novo Nordisk A/S
The FDA completed an inspection of Novo Nordisk A/S on Mar 7, 2014 in Kalundborg. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Mar 7, 2014
- Fiscal Year
- 2014
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Kalundborg (Denmark)